Skip to content
Screener

D&A at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.96B+0.8%
Globus Medical logo
Globus MedicalGMED
$69.5M-1.6%
Alphatec Holdings logo
Alphatec HoldingsATEC
$19.14M-3.9%
Medtronic logo
MedtronicMDT
$716M-14.8%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$86K-16.5%
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
$1.62M+26.5%

Other financials

Income statement

See full
Revenue$18.9M+56.7%
Gross profit$14.5M+64.0%
Operating income-$11.0M-69.7%
Net income-$10.5M-55.3%
EPS (diluted)-$0.39+73.5%

Balance sheet

See full
Cash & equivalents$46.2M+38.2%
Total debt$21.9M+23.8%
Total equity$84.2M+201%
Total assets$118.2M+122%

Cash flow

See full
Operating cash flow-$7.4M-4.5%
CapEx$121.0K-63.0%
Free cash flow-$7.5M-1.5%

Valuation

See full
Market cap$377.32M+11.1%
Enterprise value$353M
P/S

Profitability

See full
Gross margin76.6%+2.6pp
Operating margin-61.1%-3.1pp
Net margin-57.4%-6.2pp
FCF margin-54.6%-10.6pp

Returns & leverage

See full
Return on equity-6,196.9%
Debt / equity0.3×
Current ratio8.8×+4.0×

Where this comes from

Reported directly by Carlsmed, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The source filing: Carlsmed, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:10 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001794546-26-000016

FAQ

What is Carlsmed, Inc.'s D&A?
Carlsmed, Inc. (CARL) reported D&A of $130K in Q2 2026.
How has Carlsmed, Inc.'s D&A changed year-over-year?
Carlsmed, Inc.'s D&A increased by 113.1% year-over-year, from $61K to $130K.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Ask your AI about Carlsmed, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude